Barclays Maintains Equal-Weight on Tandem Diabetes Care, Raises Price Target to $20

Benzinga · 2d ago
Barclays analyst Christopher Pasquale maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight and raises the price target from $18 to $20.